株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

Array BioPharma Inc. - 製品パイプライン分析

Array BioPharma Inc - Product Pipeline Review - 2016

発行 Global Markets Direct 商品コード 224607
出版日 ページ情報 英文 71 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.35円で換算しております。
Back to Top
Array BioPharma Inc. - 製品パイプライン分析 Array BioPharma Inc - Product Pipeline Review - 2016
出版日: 2016年12月30日 ページ情報: 英文 71 Pages
概要

Array BioPharma Inc.は、癌や炎症性疾患治療のための標的小分子薬剤の開発と商品化に注力するバイオ製薬会社です。

当レポートでは、Array BioPharma Inc.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Array BioPharma Inc.の基本情報

Array BioPharma Inc.の概要

  • 主要情報
  • 企業情報

Array BioPharma Inc.:R&Dの概要

  • 主な治療範囲

Array BioPharma Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ
  • アウトライセンス製品
    • アウトライセンス製品/併用療法モダリティ

Array BioPharma Inc.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ
  • ■Array BioPharma Inc.:薬剤プロファイル
  • ARRY-502
  • ARRY-520
  • ARRY-797
  • ARRY-380
  • ARRY-614
  • AR-460770
  • AR-523
  • AR-786
  • ARRY-005
  • ARRY-006
  • ARRY-111
  • ARRY-981
  • Drugs Targeting Inflammation Pathway
  • Small Molecule To Inhibit B-Raf Kinase For Cancer

Array BioPharma Inc.:パイプライン分析

  • 薬効分類別
  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Array BioPharma Inc.:最近のパイプライン動向

Array BioPharma Inc.:休止中のプロジェクト

Array BioPharma Inc.:開発が中止されたパイプライン製品

  • 開発が中止されたパイプライン製品のプロファイル
    • ARRY-797
  • ■Array BioPharma Inc.:企業発表

Array BioPharma Inc.:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC08184CDB

Summary

Global Markets Direct's, 'Array BioPharma Inc - Product Pipeline Review - 2016', provides an overview of the Array BioPharma Inc's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Array BioPharma Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Array BioPharma Inc
  • The report provides overview of Array BioPharma Inc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Array BioPharma Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Array BioPharma Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Array BioPharma Inc's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Array BioPharma Inc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Array BioPharma Inc's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Array BioPharma Inc Snapshot
    • Array BioPharma Inc Overview
    • Key Facts
  • Array BioPharma Inc - Research and Development Overview
    • Key Therapeutic Areas
  • Array BioPharma Inc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Array BioPharma Inc - Pipeline Products Glance
    • Array BioPharma Inc - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Array BioPharma Inc - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Array BioPharma Inc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Array BioPharma Inc - Drug Profiles
    • AR-00457679 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • AR-460770 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • AR-523 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • AR-786 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • ARRY-111 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • ARRY-382 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • ARRY-797 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • ARRY-954 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • binimetinib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • binimetinib + encorafenib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • encorafenib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules for Inflammation - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Array BioPharma Inc - Pipeline Analysis
    • Array BioPharma Inc - Pipeline Products by Target
    • Array BioPharma Inc - Pipeline Products by Route of Administration
    • Array BioPharma Inc - Pipeline Products by Molecule Type
    • Array BioPharma Inc - Pipeline Products by Mechanism of Action
  • Array BioPharma Inc - Dormant Projects
  • Array BioPharma Inc - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • ARRY-797
      • AZD-8330
      • binimetinib
      • GDC-0425
      • GDC-0994
      • Mutant cKIT Inhibitor for GIST
      • rabusertib
      • selumetinib sulfate
  • Array BioPharma Inc - Company Statement
  • Array BioPharma Inc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Array BioPharma Inc, Key Facts
  • Array BioPharma Inc - Pipeline by Indication, 2016
  • Array BioPharma Inc - Pipeline by Stage of Development, 2016
  • Array BioPharma Inc - Monotherapy Products in Pipeline, 2016
  • Array BioPharma Inc - Combination Treatment Modalities in Pipeline, 2016
  • Array BioPharma Inc - Partnered Products in Pipeline, 2016
  • Array BioPharma Inc - Partnered Products/ Combination Treatment Modalities, 2016
  • Array BioPharma Inc - Out-Licensed Products in Pipeline, 2016
  • Array BioPharma Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016
  • Array BioPharma Inc - Pre-Registration, 2016
  • Array BioPharma Inc - Phase III, 2016
  • Array BioPharma Inc - Phase II, 2016
  • Array BioPharma Inc - Phase I, 2016
  • Array BioPharma Inc - Preclinical, 2016
  • Array BioPharma Inc - Discovery, 2016
  • Array BioPharma Inc - Pipeline by Target, 2016
  • Array BioPharma Inc - Pipeline by Route of Administration, 2016
  • Array BioPharma Inc - Pipeline by Molecule Type, 2016
  • Array BioPharma Inc - Pipeline Products by Mechanism of Action, 2016
  • Array BioPharma Inc - Dormant Developmental Projects,2016
  • Array BioPharma Inc - Discontinued Pipeline Products, 2016
  • Array BioPharma Inc, Other Locations

List of Figures

  • Array BioPharma Inc - Pipeline by Top 10 Indication, 2016
  • Array BioPharma Inc - Pipeline by Stage of Development, 2016
  • Array BioPharma Inc - Monotherapy Products in Pipeline, 2016
  • Array BioPharma Inc - Combination Treatment Modalities in Pipeline, 2016
  • Array BioPharma Inc - Partnered Products in Pipeline, 2016
  • Array BioPharma Inc - Out-Licensed Products in Pipeline, 2016
  • Array BioPharma Inc - Pipeline by Top 10 Target, 2016
  • Array BioPharma Inc - Pipeline Route of Administration, 2016
  • Array BioPharma Inc - Pipeline by Molecule Type, 2016
  • Array BioPharma Inc - Pipeline Products by Top 10 Mechanism of Action, 2016
Back to Top